HOUSTON,
TEXAS (July 10, 2018) – Procyrion, Inc., a medical
device company developing a catheter-deployed micropump for the management of
chronic heart failure, announced today it has hired three additional
team members to
support the advancement of its intra-aortic heart pump, AortixTM,
for use in NYHA Class III-IV heart
failure patients. Patricia DaSilva, Margo Fendrich, and Aaron Stone will
focus on product development and operations, further strengthening the
company’s team as they push toward clinical studies.
“We’ve spent the past 12 months finetuning the design of Aortix and
closing a $16 million Series C. Now, we are in a rapid growth phase to support
continued development of the Aortix system,” said Ben Hertzog, Chief Executive
Officer of Procyrion. “We are excited to have Patricia, Margo and Aaron join
the Procyrion team. They bring a mix of
technical and…